By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enterome, a privately held biomarker development firm, has raised €5 million ($6.6 million) in a series A round of private funding, it said Thursday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.